(Q35086974)

6 August 2017

1 reference

title

Applying multiple interventions in chronic kidney disease (English)

1 reference

6 August 2017

Brendan J Barrett

1

1 reference

6 August 2017

publication date

1 March 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

16

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

157-164

1 reference

Longitudinal studies on the rate of decline in renal function with age.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2003.16032.X

End-stage renal disease attributable to diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2003.16032.X

Early predictors of 15-year end-stage renal disease in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2003.16032.X

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2003.16032.X

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2003.16032.X

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2003.16032.X

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2003.16032.X

Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2003.16032.X

Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. HANE Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2003.16032.X

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2003.16032.X

Late diagnosis of chronic renal failure and mortality on maintenance dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2003.16032.X

Diabetic nephropathy: how effective is treatment in clinical practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2003.16032.X

Chronic kidney disease: why is current management uncoordinated and suboptimal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-139X.2003.16032.X

10.1046/J.1525-139X.2003.16032.X

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference